EUVIMEDEUVIMED entdecken
Crossref

Preliminary Evidence for Perturbation‐Based tACS‐EEG Biomarkers of Gamma Activity in Alzheimer's Disease

Annalisa Palmisano, Luke R Pezanko, Davide Cappon, Elisa Tatti, Joanna Macone, Giacomo Koch, Carmelo L Smeralda, Sara M Romanella, Giulio Ruffini, Davide Rivolta, Daniel Z Press, Alvaro Pascual-Leone und 2 weitere

International Journal of Geriatric Psychiatry · 2025

DOI: 10.1002/gps.70025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Geriatric Psychiatry, 2025. Verfasst von Annalisa Palmisano und 13 weiteren Autor:innen. Beteiligte Einrichtung: Precision Neuroscience & Neuromodulation Program, Gordon Center for Medical Imaging, Massachusetts General Hospital, Harvard Medical School, Boston, …. Hauptthemen laut MEDLINE: Alzheimer Disease, Gamma Rhythm, Electroencephalography, Transcranial Direct Current Stimulation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 79 Literaturangaben. Gefördert von: European Research Council, Association for Frontotemporal Degeneration, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Alzheimer's disease (AD) is characterized by impaired inhibitory circuitry and GABAergic dysfunction, which is associated with reduced fast brain oscillations in the gamma band (γ, 30–90 Hz) in several animal models. Investigating such activity in human patients could lead to the identification of novel biomarkers of diagnostic and prognostic value. The current study aimed to test a multimodal “Perturbation‐based” transcranial Alternating Current Stimulation‐Electroencephalography (tACS)‐EEG protocol to detect how responses to tACS in AD patients correlate with patients' clinical phenotype.

Methods

Fourteen participants with mild to moderate dementia due to AD underwent a baseline assessment including cognitive status, peripheral neuroinflammation, and resting‐state (rs)EEG. The tACS‐EEG recordings included brief (6′) tACS blocks of gamma (i.e., 40 Hz) stimulation administered through 4 different montages, with Pre/Post 32‐Channels EEG for each block. Changes in tACS‐EEG and rsEEG γ band power with respect to baseline were adopted as a metric of induction and compared with cognitive scores and neuroinflammatory biomarkers.

Results

We found positive correlations between 40 Hz‐induced γ activity in fronto‐central‐parietal areas and patient cognitive status and negative ones with neuroinflammatory markers. Participants with greater cognitive impairment exhibited less γ induction and higher peripheral neuroinflammation. The same analysis performed with spectral power from baseline rsEEG resulted in no significant correlations, promoting the value of tACS‐based perturbation for capturing individual differences in pathology‐related brain features.

Conclusions

Our work suggests a link between tACS‐induced γ band spectral power and clinical severity, with weaker γ induction corresponding to more severe clinical/cognitive impairment. This study provides preliminary support for the development of novel physiological biomarkers and therapeutic targets based on disease severity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseGamma RhythmElectroencephalographyTranscranial Direct Current StimulationHumansMaleFemaleAgedBiomarkersAged, 80 and overMiddle Aged

Stichwörter der Autor:innen

Alzheimer's diseasebiomarkersgamma activitytranscranial alternating current stimulation

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Precision Neuroscience & Neuromodulation Program, Gordon Center for Medical Imaging, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Berenson-Allen Center for Noninvasive Brain Stimulation, Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
  • Department of Education, Psychology, and Communication, University of Bari Aldo Moro, Bari, Italy.
  • Chair of Lifespan Developmental Neuroscience, TUD Dresden University of Technology, Dresden, Germany.
  • CUNY School of Medicine, New York City, New York, USA.
  • Santa Lucia Foundation, Rome, Italy.

ORCID-Profile: Emiliano Santarnecchi

Förderung

  • European Research Council
  • Association for Frontotemporal Degeneration
  • NIH HHS
  • Alzheimer's Drug Discovery Foundation
  • National Institutes of Health

Zitieren

APA

Palmisano, A., Pezanko, L. R., Cappon, D., Tatti, E., Macone, J., Koch, G., Smeralda, C. L., Romanella, S. M., Ruffini, G., Rivolta, D., Press, D. Z., Pascual-Leone, A., El-Fakhri, G., & Santarnecchi, E. (2025). Preliminary Evidence for Perturbation‐Based tACS‐EEG Biomarkers of Gamma Activity in Alzheimer's Disease. International Journal of Geriatric Psychiatry. https://doi.org/10.1002/gps.70025

Vancouver

Palmisano A, Pezanko LR, Cappon D, Tatti E, Macone J, Koch G, et al. Preliminary Evidence for Perturbation‐Based tACS‐EEG Biomarkers of Gamma Activity in Alzheimer's Disease. International Journal of Geriatric Psychiatry. 2025. doi:10.1002/gps.70025

BibTeX
@article{Palmisano2025,
  author = {Palmisano, Annalisa and Pezanko, Luke R and Cappon, Davide and Tatti, Elisa and Macone, Joanna and Koch, Giacomo and Smeralda, Carmelo L and Romanella, Sara M and Ruffini, Giulio and Rivolta, Davide and Press, Daniel Z and Pascual-Leone, Alvaro and El-Fakhri, Georges and Santarnecchi, Emiliano},
  title = {Preliminary Evidence for Perturbation‐Based tACS‐EEG Biomarkers of Gamma Activity in Alzheimer's Disease},
  journal = {International Journal of Geriatric Psychiatry},
  year = {2025},
  doi = {10.1002/gps.70025}
}
Kostenlos starten →